Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis

Journal of Neuroscience Research

Volumn 78, Issue 2, 2004, Pages 250-258

  Nitta, Atsumi ^a   Nishioka, Hirofumi ^b   Fukumitsu, Hidefumi ^b   Furukawa, Yoshiko ^b   Sugiura, Haruo ^b   Shen, Liya ^c   Furukawa, Shoei ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Brain derived neurotrophic factor; Dopamine; FK506; Glial cell line derived neurotrophic factor; Immunophilin; Leu Ile; Mice

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCINEURIN; CONCANAVALIN A; DIPEPTIDE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; IMMUNOPHILIN; INTERLEUKIN 2; LEUCYLISOLEUCINE; LEUCYLPROLINE; METHAMPHETAMINE; OXIDOPAMINE; PROLYLISOLEUCINE; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DENERVATION; EMBRYO; HYDROPHOBICITY; MESENCEPHALON; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCINEURIN; CELL DEATH; CELLS, CULTURED; CORPUS STRIATUM; DIPEPTIDES; DOPAMINE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HIPPOCAMPUS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-2; MESENCEPHALON; MICE; MOTOR ACTIVITY; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; RATS;

EID: 4744356752     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20258     Document Type: Article

References (49)

1. Awatsuji H, Furukawa Y, Hirota M, Murakami Y, Nii S, Furukawa S, Hayashi K. 1993a. Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion. J Neurosci Res 34:539-545.
2. Awatsuji H, Furukawa Y, Nakajima M, Furukawa S, Hayashi K. 1993b. Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain. J Neurosci Res 35:305-311.
3. Bowenkampt KE, Hoffman AF, Gerhardt GA, Henry MA, Biddle PT, Hoffer BJ, Granholm AC. 1995. Glial cell-line derived neurotrophic factor supports survaival of injured midbrain DA neurons. J Comp Neurol 355:479-486.
4. Butcher SP, Hanshall D, Teramura Y, Iwasaki K, Sharkey J. 1997. Neurroprotective actions of FK506 in experimental stroke in vivo evidence against an antiexcitotoxic mechanism. J Neurosci 17:6939-6946.
5. Cameron AM, Nucifora FC, Fung ET, Livingston DJ, Aldape RA, Ross CA, Snyder SH. 1997. FKBT12 binds the inositol 1,4,5-triphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FKBP-like domain. J Biol Chem 272:27582-27588.
6. Collins F, Hoffer BJ, Gerhardt GA. 1996. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-260.
7. Fukumitsu H, Sometani A, Ohmiya M, Nitta A, Nomoto H, Furukawa Y, Furukawa S. 1999. Induction of a physiologically active brain-derived neurotrophic factor in the infant rat brain by peripheral administration of 4-methylcatechol. Neurosci Lett 274:115-118.
8. Furukawa S, Kamo I, Furukawa Y, Akazawa S, Satoyoshi E, Itoh K, Hayashi K. 1983. A highly sensitive enzyme immunoassay for mouse beta nerve growth factor. J Neurochem 40:734-744.
9. Gaymes TJ, Cabrat M, Siemion IZ, Kay JE. 1997. Cyclolinopeptide A (CLA) mediates its immunosuppressive activity through cyclophilin-dependent calcineurin inactivation. FEBS Lett 418:224-227.
10. Gerlach M, Riederer P, Pzuntek H, Youdim MB. 1991. MPTP mechanisms of neurotoxisity and their implications for Parkinson's disease. Eur J Pharmacol 208:273-286.
11. Gold BG, Storm-Dickerson T, Austin DR. 1994. The immunosuppressant FK506 increased functional recovery and nerve regeneration following peripheral nerve injury. Restor Neurol Neuorosci 6:287-296.
12. Gold BG, Zeleny-Pooley M, Wang MS, Chathrvedi P, Armistead DM. 1997. A nonimmunosuppressant FKBP-12 ligand increase nerve regeneration. Exp Neurol 147:269-278.
13. Gozes I, Peal O, Giladi E, Davidson A, Ashir-Fabian O, Rubinraut S, Fridkin M. 1999. Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design. Proc Natl Acad Sci U S A 96:4143-4148.
14. Granholm A-C, Mott JL, Bowenkamp K, Eken S, Henry S, Hoffer BJ, Lapchak PA, Palmer MR, van Horne C, Gerhardt GA. 1997a. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res 116:29-33.
15. Granholm A-C, Srivastava N, Mott JL, Henry S, Henry M, Westphal H, Pichel JG, Shen L, Hoffer BJ. 1997b. Morphological alterations in the peripheral and central nervous system of mice lacking glial cell line derived neurotrophic factor (GDNF): immunohistochemical studies. J Neurosci 17:1168-1178.
16. Hallbook F, Ibanez CF, Persson H. 1991. Evaluation studied of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 6:845-858.
17. Hoffer BJ, Hoffman A, Bowenlamp K, Huettl P, Hudson J, Martin D, Lin L-FH, Gerhardt G. 1994. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain DA neurons in vivo. Neurosci Lett 182:107-111.
18. Hohn A, Leibrock J, Bailey K, Barde YA. 1990. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344:339-341.
19. Jonhansson M, Friedmann M, Hoffer B, Stromburg I. 1995. Effects of GDNF on developinf and mature mesencephalic grafts in oculo. Exp Neurol 134:25-34.
20. Kaechi K, Furukawa Y, Ikegami R, Nakamura N, Omae F, Hashimoto Y, Hayashi K, Furukawa S. 1993. Pharmacological induction of physiologically active nerve growth factor in rat peripheral nervous system. J Pharmacol Exp Ther 264:321-326.
21. Knusel B, Winslow JW, Rosenthal A, Borto LE, Seid DP, Nikolies K, Hefti F. 1991. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc Natl Acad Sci U S A 88:9621-9625.
22. Kochi S, Takanaga H, Matsuno H, Naito M, Tsuruo T, Sawada Y. 1999. Effects of cyclosporine A or tacrolimus on the function of blood-brain barrier cells. Eur J Pharmacol 372:287-295.
23. Lee RKK, Knapp S, Wuetman RJ. 1999. Prostaglandin E2 stimulates amyloid precursor protein gene expression: inhibition by immunosuppressants. J Neurosci 19:940-947.
24. Leibrock J, Lottspeich F, Hohn A, Hofer M, Hangere B, Masiakowski P, Thoenen H, Barde YA. 1989. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149-151.
25. Linder MD, Winn SR, Baetge EE, Hammang JP, Gebrile FT, Doherty E, MaDermatt PE, Frydel B, Ullman MD, Schallert T. 1995. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletion and parkinsonian symptoms. Exp Neurol 132:62-70.
26. Nitta A, Murase K, Furukawa Y, Hayashi K, Hasegawa T, Nabeshima T. 1993. Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats. Eur J Pharmacol 250:23-30.
27. Nitta A, Murakami Y, Furukawa Y, Kawatsura W, Hayashi K, Yamada K, Hasegawa T, Nabeshima T. 1994. Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats. Naunyn Schmiedebergs Arch Pharmacol 349:401-407.
28. Nitta A, Furukawa S, Nabeshima T. 1997. Clinical potential of compounds stimulate nerve growth factor production. In: Mattoson MP, editor. Neuroprotective signal transduction. Totowa, NJ: Humana Press, p 95-110.
29. Nitta A, Ito M, Fukumitsu H, Ohmiya M, Ito H, Sometani A, Nomoto H, Furukawa Y, Furukawa S. 1999a. 4-Methylcatechol increases brain-derived neurotrophic factor content and mRNA expression cultured brain cells and in rat brain in vivo. J Pharmacol Exp Ther 291:1276-1283.
30. Nitta A, Ohmiya M, Jin-nouchi T, Sometani A, Asami A, Kinukawa H, Fukumitsu H, Nomoto H, Furukawa S. 1999b. Endogenous neurotrophin-3 is retrogradely transported in the rat sciatic nerve. Neuroscience 88:679-685.
31. Nitta A, Ohmiya M, Sometani A, Itoh M, Nomoto H, Furukawa Y, Furukawa S. 1999c. Brain-derived neurotrophic factor prevents neuronal cell death induced by corticosterone. J Neurosci Res 57:227-235.
32. Nitta A, Murai R, Maruyama K, Furukawa S. 2002. FK506 protects dopaminergic degeneration through induction of GDNF in rodent brain. In: Mizuno Y and Fisher A, editors. Mapping the progress of Alzheimer's and Parkinson's disease. New York, NY: Kluwer Academic/Plenum Publishers, p 463-467.
33. Phillips HS, Hains JM, Laramee GR, Rosenthal A, Winslow JW. 1990. Widespread expression of BDNF but not NT-3 by target areas of basal forebrain cholinergic neurons. Science 250:290-294.
34. Phillips JW, Diaz FG, O'Regan MH, Pilitsis JG. 2002. Effects of immunosuppressant, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex. Brain Res 957:12-24.
35. Picher JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H. 1996. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382:73-76.
36. Rose DT, Guo H, Howorth P, Chen Y, Hamilton GS, Steiner JP. 2001. The small molecule FKBP ligand GP1 1046 induces partial striatal reinnervation after intranigral 6-hydroxydopamine lesion in rats. Neurosci Lett 297:113-116.
37. Rutherford LC, DeWan A, Lauer HM, Turrigiano GG. 1997. Brain-derived neurotrophic factor mediates the activity-dependent regulation of inhibition in neocortical culture. J Neurosci 17:4527-4535.
38. Schreiber SI. 1991. Chemistry and Biology of immunophilins and their immunosuppressive ligands. Science 251:283-287.
39. Schubert D, Heinemann S, Carlisle W, Tarikas H, Kimes B, Patrick J, Steinbach JH, Culp W, Brandt BL. 1974. Clonal cell lines from the rat central nervous system. Nature 249:224-231.
40. Sometani A, Nomoto H, Nitta A, Furukawa Y, Furukwawa S. 2002. 4-Methylcatechol stimualates phosophorylation of Trk family neurotrophin receptors and MAP kinases in cultured rat cortical neurons. J Neurosci Res 70:335-339.
41. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A. 1989. FK506 for liver, kidney, and pancreas transplantation. Lancet 2:1000-1004.
42. Steiner JP, Dawson TM, Fotuhi M, Glatt CE, Snowman AM, Cohen N, Snyder SH. 1992. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358:584-587.
43. Steiner JP, Connolly MA, Valentine HL, Hamilton GS, Dawson TM, Hester L, Snyder SH. 1997b. Neurotrophic actions of nonimmunosuppressive analogs of immunosuppressive drugs FK506, rapamycin and cyclosporine A. Nat Med 3:421-428.
44. Steiner JP, Hamilton GS, Ross DT, Valentine HL, Guo H, Connolly MA, Liang S, Ramsey C, Li JH, Huang W, Howorth P, Soni R, Fuller M, Sauer H, Nowotnik AC, Suzdak PD. 1997a. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci U S A 94:2019-2024.
45. Sugiura H, Sugiura H, Hishida H, Inaba R, Mirbod SM, Iwata H. 2000. Immunomodulation by 8-week voluntary exercise in mice. Acta Physiol Scand 168:413-420.
46. Thomson AW. 1989. FK506-how much potential? Immunol Today 10:6-9.
47. Tomac A, Lindqvist E, Lin L, Ogren SO, Young D, Hoffer BL, Olson L. 1995. Protection and repair of the nigrostriatal DA system by GDNF in vivo. Nature 373:335-343.
48. Tomac A, Widenfalk J, Lin LH, Kohno T, Ebendal T, Hodder BL, Olson L. 1996. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in adult. Proc Natl Acad Sci U S A 92:8274-8278.
49. Zafra F, Hengerer B, Leibrock J, Thoenen H, Lindholm D. 1990. Activity dependent regulation of BDNF and NGF mRNA in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J 9:3545-3550.